EP3181119A1 — Semifluorinated alkane compositions for use in the treatment of keratoconjunctivitis sicca
Assigned to Novaliq GmbH · Expires 2017-06-21 · 9y expired
What this patent protects
A composition consisting of a semifluorinated alkane of the formula F(CF 2),(CH 2) mH, wherein n is an integer from the range of 3 to 8 and m is an integer from the range of 3 to 10, and optionally one or more further excipients may be used as a medicine in the treatment of kerat…
USPTO Abstract
A composition consisting of a semifluorinated alkane of the formula F(CF 2),(CH 2) mH, wherein n is an integer from the range of 3 to 8 and m is an integer from the range of 3 to 10, and optionally one or more further excipients may be used as a medicine in the treatment of keratoconjunctivitis sicca (dry eye) or a symptom or condition associated therewith
Drugs covered by this patent
- Miebo (PERFLUOROHEXYLOCTANE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.